Morgan Stanley, JPMorgan, Jefferies, TD Securities and Leerink acted as joint book running managers for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KYMR:
- Kymera Therapeutics price target raised to $60 from $54 at H.C. Wainwright
- Kymera Therapeutics price target raised to $59 from $55 at BTIG
- Kymera Therapeutics price target lowered to $53 from $57 at Wells Fargo
- Optimistic Outlook for Kymera Therapeutics Amid Strategic Partnerships and Strong KT-621 Prospects
- Closing Bell Movers: Micron surges on earnings, retreats on call comments